Product Code: ETC5312497 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The New Zealand Quinine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Growth accelerates to -2.94% in 2026, following an initial rate of -3.35%, before easing to -7.79% at the end of the period.
By 2027, the Quinine market in New Zealand is anticipated to reach a growth rate of -3.15%, as part of an increasingly competitive Asia region, where China remains at the forefront, supported by India, Japan, Australia and South Korea, driving innovations and market adoption across sectors.
Quinine, derived from the bark of the cinchona tree, is known for its antimalarial properties and is also used in the production of tonic water. In New Zealand, the quinine market serves pharmaceutical companies, beverage manufacturers, and research institutions involved in drug development and natural products extraction. Market dynamics include fluctuations in quinine supply, regulatory considerations, and research on alternative antimalarial treatments.
The quinine market in New Zealand is driven by its applications in pharmaceuticals, particularly in the treatment of malaria. The demand for antimalarial drugs remains a primary driver. Additionally, quinine`s use in beverages, notably tonic water, contributes to market growth. Regulatory support and ongoing research into quinine`s medicinal properties also play a role.
The rabies vaccine market in New Zealand encounters challenges in terms of vaccine accessibility and public health awareness. Despite the importance of vaccination, ensuring widespread access and addressing vaccine hesitancy remain significant issues. Regulatory hurdles and maintaining cold chain logistics for vaccine distribution also pose challenges.
Regulations in the quinine market ensure product safety and quality for medicinal and industrial uses. The government oversees standards for quinine production, labeling, and distribution to safeguard public health.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Quinine Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Quinine Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Quinine Market - Industry Life Cycle |
3.4 New Zealand Quinine Market - Porter's Five Forces |
3.5 New Zealand Quinine Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.6 New Zealand Quinine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 New Zealand Quinine Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 New Zealand Quinine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the health benefits of quinine consumption |
4.2.2 Growing demand for natural and organic products in the market |
4.2.3 Rising prevalence of diseases like malaria and leg cramps, for which quinine is used as a treatment |
4.3 Market Restraints |
4.3.1 Stringent regulations on quinine production and distribution |
4.3.2 Fluctuations in raw material prices affecting the overall production cost |
4.3.3 Competition from alternative treatments and substitutes in the market |
5 New Zealand Quinine Market Trends |
6 New Zealand Quinine Market Segmentations |
6.1 New Zealand Quinine Market, By Mode of Administration |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Quinine Market Revenues & Volume, By Oral Administration, 2021-2031F |
6.1.3 New Zealand Quinine Market Revenues & Volume, By Intravenous Administration, 2021-2031F |
6.1.4 New Zealand Quinine Market Revenues & Volume, By Intramuscular Administration, 2021-2031F |
6.1.5 New Zealand Quinine Market Revenues & Volume, By Others, 2021-2031F |
6.2 New Zealand Quinine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Quinine Market Revenues & Volume, By Antimalarial, 2021-2031F |
6.2.3 New Zealand Quinine Market Revenues & Volume, By Antipyretic, 2021-2031F |
6.2.4 New Zealand Quinine Market Revenues & Volume, By Others, 2021-2031F |
6.3 New Zealand Quinine Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Quinine Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.3 New Zealand Quinine Market Revenues & Volume, By Clinics, 2021-2031F |
6.3.4 New Zealand Quinine Market Revenues & Volume, By Ambulatory Surgical Centers, 2021-2031F |
6.3.5 New Zealand Quinine Market Revenues & Volume, By Others, 2021-2031F |
7 New Zealand Quinine Market Import-Export Trade Statistics |
7.1 New Zealand Quinine Market Export to Major Countries |
7.2 New Zealand Quinine Market Imports from Major Countries |
8 New Zealand Quinine Market Key Performance Indicators |
8.1 Number of health and wellness campaigns promoting quinine consumption |
8.2 Percentage of consumers preferring natural and organic quinine products |
8.3 Number of reported cases of diseases where quinine is prescribed |
8.4 Research and development investment in quinine-based products |
8.5 Consumer satisfaction and perception surveys on quinine products |
9 New Zealand Quinine Market - Opportunity Assessment |
9.1 New Zealand Quinine Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.2 New Zealand Quinine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 New Zealand Quinine Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 New Zealand Quinine Market - Competitive Landscape |
10.1 New Zealand Quinine Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Quinine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |